ArticlebioRxiv : the preprint server for biology2025
Investigation of CD36 interactome provides insights into multimolecular complexes necessary for anti-angiogenic signalling.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Signal transduction is a fundamental process that enables cells to adapt to external cues and organize adequate responses including survival, death, growth, and homeostasis. A key mechanism modulating signal transduction relies on the formation of multimolecular complexes optimized for specificity, modularity and signal amplification. The scavenger receptor CD36, which binds diverse ligands in different cellular contexts, illustrates this principle. To uncover the nature of CD36 multimolecular complexes, we employed a proximity biotinylation labeling approach on human endothelial cells, where CD36 binds to thrombospondin-1 (TSP-1) to initiate a signaling cascade promoting programmed cell death. Using biotin capture and mass spectrometry protein identification, we uncovered a list of proteins in the vicinity of CD36. This list of candidates was refined by proximity ligation assays. The relationship between key CD36 interacting molecules, in particular active integrin beta-1 (ITGB1) and CD9, was further decoded by conditional colocalization analysis, providing support for their association within a tri-molecular complex. The implication of selected candidates in the signaling function of CD36 was further evaluated using shRNA knockdown, revealing that active ITGB1 is essential for Fyn activation downstream of CD36, with the tetraspanin playing a connecting role between CD36 and active ITGB1. Our approach to investigating CD36 complexes emphasizes the complexity and fundamental role of protein-protein interactions and coordination in the context of transmembrane signal transduction.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.